Colorectal cancers express higher levels of HIBCH, and its function depends on its localization in mitochondria, and blocking the function of HIBCH not only can inhibit the growth of cancer cells but also can improve the efficacy of targeted therapy (35). Here, HIBCH is linked to colorectal cancer.